Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Interventional Cardiology Fellowship

Houston Methodist

Interventional Cardiology Fellowship Training Program
ACGME ID: 1524814171

Program Overview

The Interventional Cardiology Fellowship at Houston Methodist Hospital is a one-year ACGME-approved program organized under the directorship of Dr. Neal S. Kleiman.  The fellowship functions as an integral component of the subspecialty fellowship in Cardiology and the categorical residency program in Internal Medicine.  During the year of interventional training, fellows are expected to master the techniques involved in coronary intervention, while developing perspective on procedural risk and benefit, patient selection and clinical decision-making in cardiovascular patient care.  At the end of the year, fellows should function as independent operators during interventional procedures.  The program adheres to the tenets outlined in the ACGME training requirements, ACC COCATS guidelines document and the AHA statement on clinical competency in interventional cardiology. 

Objectives of the Fellowship

The primary goal of the Interventional Cardiology Fellowship is to train future leaders in the field of Interventional Cardiology.  The fellowship program provides the opportunity to acquire procedural expertise including but not limited to:

  • Percutaneous transluminal coronary angioplasty
  • Balloon angioplasty
  • Stent deployment
  • Rotational artherectomy
  • Directional artherectomy
  • Laser artherectomy
  • Mechanical thrombectomy
  • Rheolytic trombectomy
  • Distal protection devices

In addition to learning techniques for percutaneous coronary intervention, fellows will be exposed to the following:

  • Percutaneous balloon valvuloplasty
  • Percutaneous valve implantation/replacement
  • Transcatheter closure of intracardiac communications
  • Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
  • Catheter treatment of congenital heart disease

Clinical investigations include the use of novel devices for percutaneous treatment of coronary artery disease, non-coronary cardiac interventions such as percutaneous valve replacement, drug-eluting stent studies, stem cell and angiogenesis factor treatment for patients with end-state coronary and peripheral arterial disease and novel imaging technologies. 

Fellows graduating from the one-year program will easily exceed the minimum ACGME requirement of 250 coronary interventions. Our curriculum meets the requirements specified by the American College of Cardiology for interventionalist; and our high volume and high level of case complexity provide an excellent foundation to develop expertise as an independent operator. 

Facilities

All training will take place in the Houston Methodist Hospital (915 beds).  The Methodist DeBakey Heart & Vascular Center Cardiac Catheterization laboratory facilities are located in Methodist.  The laboratory is comprised of 10 state-of-the-art, high-resolution digital fluoroscopy units.  Our facilities also include a hybrid operating room.  We also have an 18-bed coronary intensive care unit adjacent to the catheterization laboratory.  Our facilities also include a state-of-the-art Research Institute which houses the Methodist Institute for Technology, Innovation, and Education (MITIE) which is an educational resource for health care professionals and trainees who wish to improve their skills and acquire new ones through procedural simulation technology.